QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 btig-maintains-buy-on-accuray-lowers-price-target-to-4

BTIG analyst Marie Thibault maintains Accuray (NASDAQ:ARAY) with a Buy and lowers the price target from $5 to $4.

 accuray-affirms-fy2026-sales-guidance-of-471000m-485000m-vs-475150m-est

Accuray (NASDAQ:ARAY) affirms FY2026 sales outlook from $471.000 million-$485.000 million to $471.000 million-$485.000 million ...

 accuray-q1-eps-016-misses-006-estimate-sales-93942m-beat-91350m-estimate

Accuray (NASDAQ:ARAY) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.06) by ...

 accuray-reports-preliminary-q1-fy26-revenue-of-925m-94m-product-sales-lag-in-eimea-and-china-ebitda-at-4m

Fiscal 2026 First Quarter Financial ResultsAccuray expects to release summary financial information for its fiscal 2026 first q...

 accuray-appoints-steve-la-neve-as-ceo-effective-immediately-succeeding-suzanne-winter

Accuray Incorporated (NASDAQ: ARAY) today announced it is engaging in a significant organizational, strategic, and operational ...

 accuray-announces-first-patients-treated-through-5d-clinics-in-melbourne-using-cyberknife-s7-system

5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Ra...

 accuray-and-uw-smph-sign-mou-to-advance-online-adaptive-radiotherapy-on-accuray-helical-radiation-treatment-delivery-platform

Accuray Incorporated (NASDAQ:ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced tod...

 accuray-inc-advances-adaptive-radiotherapy-with-introduction-of-accuray-stellar-solution

New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive ...

 btig-maintains-buy-on-accuray-raises-price-target-to-5

BTIG analyst Maria Thibault maintains Accuray (NASDAQ:ARAY) with a Buy and raises the price target from $4 to $5.

 accuray-sees-fy2026-sales-471000m-485000m-vs-454740m-est

Accuray (NASDAQ:ARAY) sees FY2026 sales of $471.000 million-$485.000 million vs $454.740 million analyst estimate.

 accuray-q4-eps-001-misses-002-estimate-sales-127543m-beat-123774m-estimate

Accuray (NASDAQ:ARAY) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 44...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION